Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Preparation Optimization and Immunological Activity Studies of Portulaca oleracea L. Polysaccharides Liposomes

Author(s): Yan Li, Guiyan Jia, Tao Li, Xiechen Zhou, Hui Zhao, Junyang Cao, Zijan Guan and Rui Zhao*

Volume 30, Issue 10, 2024

Published on: 21 February, 2024

Page: [786 - 797] Pages: 12

DOI: 10.2174/0113816128279071231204071210

Price: $65

Abstract

Aims: This study combines traditional Chinese medicine polysaccharides with nanomaterials to enhance drug bioavailability and immunological activity.

Background: The study of polysaccharide preparation, structure identification, pharmacological activity, and mechanism of action is deepening, but the research combined with the new drug delivery system is relatively weak, so the application of polysaccharides is still facing great limitations. In order to prolong the action time of polysaccharides and improve their bioavailability, liposome has become the most promising delivery carrier.

Objectives: The purpose of this study was to optimize the preparation process of Portulaca oleracea L. polysaccharides liposomes (POL-PL) and evaluate the immunoactivity in vitro.

Methods: POL-PL was prepared by reverse evaporation, and the preparation process was optimized using the response surface methodology. The characteristic analysis of POL-PL was detected by the indicators including morphology, particle size, zeta potential, encapsulation efficiency, release, and stability. The effects of POL-PL on the proliferation and immunological activity of mouse spleen lymphocytes and RAW264.7 cells were evaluated in vitro.

Results: POL-PL is highly homogeneous in morphology and particle size, and its sustained release improves the bioavailability of Portulaca oleracea L. polysaccharides (POL-P). Moreover, POL-PL treatment significantly enhanced the proliferation and phagocytic activity of RAW264.7 cells and increased the secretion of IL-6, TNF-α, IL-1β, and NO.

Conclusion: This study suggested that POL-PL were prepared successfully by reverse evaporation method, and POL-PL had immunoenhancing activity in vitro. The results provided a theoretical basis for further application of POL-PL.

« Previous Next »
[1]
Ocampo G, Columbus JT. Molecular phylogenetics, historical biogeography, and chromosome number evolution of Portulaca (Portulacaceae). Mol Phylogenet Evol 2012; 63(1): 97-112.
[http://dx.doi.org/10.1016/j.ympev.2011.12.017] [PMID: 22210411]
[2]
YouGuo C. ZongJi S, XiaoPing C. Evaluation of free radicals scavenging and immunity-modulatory activities of Purslane polysaccharides. Int J Biol Macromol 2009; 45(5): 448-52.
[http://dx.doi.org/10.1016/j.ijbiomac.2009.07.009] [PMID: 19643128]
[3]
Shen H, Tang G, Zeng G, et al. Purification and characterization of an antitumor polysaccharide from Portulaca oleracea L. Carbohydr Polym 2013; 93(2): 395-400.
[http://dx.doi.org/10.1016/j.carbpol.2012.11.107] [PMID: 23499074]
[4]
Guo G, Yue L, Fan S, Jing S, Yan LJ. Antioxidant and antiproliferative activities of purslane seed oil. J Hypertens 2016; 5(2): 218.
[http://dx.doi.org/10.4172/2167-1095.1000218] [PMID: 27928516]
[5]
Zhao R, Gao X, Cai Y, et al. Antitumor activity of Portulaca oleracea L. polysaccharides against cervical carcinoma in vitro and in vivo. Carbohydr Polym 2013; 96(2): 376-83.
[http://dx.doi.org/10.1016/j.carbpol.2013.04.023] [PMID: 23768576]
[6]
Zhao R, Meng X, Jia G, Yu Y, Song B. Oral pre-administration of Purslane polysaccharides enhance immune responses to inactivated foot-and-mouth disease vaccine in mice. BMC Vet Res 2019; 15(1): 38.
[http://dx.doi.org/10.1186/s12917-019-1782-3] [PMID: 30683105]
[7]
Has C, Sunthar P. A comprehensive review on recent preparation techniques of liposomes. J Liposome Res 2020; 30(4): 336-65.
[http://dx.doi.org/10.1080/08982104.2019.1668010] [PMID: 31558079]
[8]
Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13(1): 238-IN27.
[http://dx.doi.org/10.1016/S0022-2836(65)80093-6] [PMID: 5859039]
[9]
Kramer RM, Archer MC, Orr MT, et al. Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach. Int J Nanomedicine 2018; 13: 3689-711.
[http://dx.doi.org/10.2147/IJN.S159839] [PMID: 29983563]
[10]
Abdellatif AAH, Aldosari BN, Al-Subaiyel A, et al. Transethosomal gel for the topical delivery of celecoxib: Formulation and estimation of skin cancer progression. Pharmaceutics 2022; 15(1): 22.
[http://dx.doi.org/10.3390/pharmaceutics15010022] [PMID: 36678651]
[11]
Wathoni N, Puluhulawa LE, Joni IM, et al. Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer. Drug Deliv 2022; 29(1): 2959-70.
[http://dx.doi.org/10.1080/10717544.2022.2120566] [PMID: 36085575]
[12]
Tandrup Schmidt S, Foged C, Smith Korsholm K, Rades T, Christensen D. Liposome-based adjuvants for subunit vaccines: Formulation strategies for subunit antigens and immunostimulators. Pharmaceutics 2016; 8(1): 7.
[http://dx.doi.org/10.3390/pharmaceutics8010007] [PMID: 26978390]
[13]
Zhang W, Ma W, Zhang J, Song X, Sun W, Fan Y. The immunoregulatory activities of astragalus polysaccharide liposome on macrophages and dendritic cells. Int J Biol Macromol 2017; 105(Pt 1): 852-61.
[http://dx.doi.org/10.1016/j.ijbiomac.2017.07.108] [PMID: 28732726]
[14]
Chen F, Wu W, Millman A, et al. Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsion. Nat Immunol 2014; 15(10): 938-46.
[http://dx.doi.org/10.1038/ni.2984] [PMID: 25173346]
[15]
Netea MG, Domínguez-Andrés J, Barreiro LB, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol 2020; 20(6): 375-88.
[http://dx.doi.org/10.1038/s41577-020-0285-6] [PMID: 32132681]
[16]
Liu C, Chen J, Chen L, Huang X, Cheung PCK. Immunomodulatory activity of polysaccharide–protein complex from the mushroom sclerotia of Polyporus rhinocerus in murine macrophages. J Agric Food Chem 2016; 64(16): 3206-14.
[http://dx.doi.org/10.1021/acs.jafc.6b00932] [PMID: 27054263]
[17]
Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther 2018; 3(1): 7.
[http://dx.doi.org/10.1038/s41392-017-0004-3] [PMID: 29560283]
[18]
Lee MK. Liposomes for enhanced bioavailability of water-insoluble drugs: in vivo evidence and recent approaches. Pharmaceutics 2020; 12(3): 264.
[http://dx.doi.org/10.3390/pharmaceutics12030264] [PMID: 32183185]
[19]
Gong H, Li W, Sun J, et al. A review on plant polysaccharide based on drug delivery system for construction and application, with emphasis on traditional Chinese medicine polysaccharide. Int J Biol Macromol 2022; 211: 711-28.
[http://dx.doi.org/10.1016/j.ijbiomac.2022.05.087] [PMID: 35588976]
[20]
Moslehi M, Mortazavi SAR, Azadi A, Fateh S, Hamidi M, Foroutan SM. Preparation, optimization and characterization of chitosan-coated liposomes for solubility enhancement of furosemide: A model BCS IV drug. Iran J Pharm Res 2020; 19(1): 366-82.
[http://dx.doi.org/10.22037/ijpr.2019.111834.13384] [PMID: 32922494]
[21]
Günther J, Seyfert HM. The first line of defence: Insights into mechanisms and relevance of phagocytosis in epithelial cells. Semin Immunopathol 2018; 40(6): 555-65.
[http://dx.doi.org/10.1007/s00281-018-0701-1] [PMID: 30182191]
[22]
Mu H, Holm R. Solid lipid nanocarriers in drug delivery: Characterization and design. Expert Opin Drug Deliv 2018; 15(8): 771-85.
[http://dx.doi.org/10.1080/17425247.2018.1504018] [PMID: 30064267]
[23]
Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharm Res 1996; 13(12): 1838-45.
[http://dx.doi.org/10.1023/A:1016085108889] [PMID: 8987081]
[24]
Smith MC, Crist RM, Clogston JD, McNeil SE. Zeta potential: A case study of cationic, anionic, and neutral liposomes. Anal Bioanal Chem 2017; 409(24): 5779-87.
[http://dx.doi.org/10.1007/s00216-017-0527-z] [PMID: 28762066]
[25]
Mohd Izham MN, Hussin Y, Aziz MNM, et al. Preparation and characterization of self nano-emulsifying drug delivery system loaded with citraland its antiproliferative effect on colorectal cells in vitro. Nanomaterials 2019; 9(7): 1028.
[http://dx.doi.org/10.3390/nano9071028] [PMID: 31323842]
[26]
Ke M, Wang H, Zhou Y, et al. SEP enhanced the antitumor activity of 5-fluorouracil by up-regulating NKG2D/MICA and reversed immune suppression via inhibiting ROS and caspase-3 in mice. Oncotarget 2016; 7(31): 49509-26.
[http://dx.doi.org/10.18632/oncotarget.10375] [PMID: 27385218]
[27]
Zhou BY, Sun JC, Li X, et al. Analysis of immune responses in mice orally immunized with recombinant pMG36e-SP-TSOL18/Lactococcus lactis and pMG36e-TSOL18/Lactococcus lactis vaccines of Taenia solium. J Immunol Res 2018; 2018: 1-12.
[http://dx.doi.org/10.1155/2018/9262631]
[28]
Chen Y, Wu Y, Xian L, et al. Effects of bush sophora root polysaccharide and its sulfate on immuno-enhancing of the therapeutic DVH. Int J Biol Macromol 2015; 80: 217-24.
[http://dx.doi.org/10.1016/j.ijbiomac.2015.06.029] [PMID: 26118485]
[29]
Lee YJ, Lee SB, Beak SK, et al. Temporal changes in immune cell composition and cytokines in response to chemoradiation in rectal cancer. Sci Rep 2018; 8(1): 7565.
[http://dx.doi.org/10.1038/s41598-018-25970-z] [PMID: 29765096]
[30]
Maeda N, Sekigawa I, Iida N, Matsumoto M, Hashimoto H, Hirose S. Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus. Scand J Rheumatol 1999; 28(3): 166-70.
[http://dx.doi.org/10.1080/03009749950154248] [PMID: 10380839]
[31]
Hussain T, Kulshreshtha KK, Yadav VS, Katoch K. CD4+, CD8+, CD3+ cell counts and CD4+/CD8+ ratio among patients with mycobacterial diseases (leprosy, tuberculosis), HIV infections, and normal healthy adults: A comparative analysis of studies in different regions of India. J Immunoassay Immunochem 2015; 36(4): 420-43.
[http://dx.doi.org/10.1080/15321819.2014.978082] [PMID: 25350657]
[32]
Seregin SS, Amalfitano A. Improving adenovirus based gene transfer: Strategies to accomplish immune evasion. Viruses 2010; 2(9): 2013-36.
[33]
Chen C, Su X, Hu Z. Immune promotive effect of bioactive peptides may be mediated by regulating the expression of SOCS1/miR 155. Exp Ther Med 2019; 18(3): 1850-62.
[http://dx.doi.org/10.3892/etm.2019.7734] [PMID: 31410147]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy